Clinical Outcomes of Pembrolizumab in Head and Neck Squamous Cell Carcinoma Subsites Excluded from the KEYNOTE-048 Trial
帕博利珠单抗治疗未纳入 KEYNOTE-048 试验的头颈部鳞状细胞癌亚部位的临床结果
期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol33010057
Yamashita, Gai; Okada, Takuro; Okamoto, Isaku; Kondo, Takahito; Ito, Tatsuya; Fujii, Shota; Kishida, Takuma; Aihara, Yusuke; Hanyu, Kenji; Ueda, Yuri; Tokashiki, Kunihiko; Sato, Hiroki; Harada, Yuki; Momiyama, Kaho; Matsuki, Takashi; Kushihashi, Yukiomi; Masubuchi, Tatsuo; Tada, Yuichiro; Yamashita, Taku; Tsukahara, Kiyoaki